ArticleJournal of neurosurgery. Case lessons2025
The gradual expansion of multiple intramedullary metastatic renal cell carcinoma in a patient with von Hippel-Lindau disease with multiple intramedullary hemangioblastomas: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with von Hippel-Lindau disease (VHLD) often have multiple intramedullary tumors, including hemangioblastoma and rarely intramedullary metastatic renal cell carcinoma (RCC). However, the incidence of intramedullary metastatic clear-cell RCC (CCRCC) comorbid with hemangioblastoma is not clear. OBSERVATIONS: The authors report a rare case of intramedullary metastatic CCRCC comorbid with multiple hemangioblastomas in a patient with VHLD. The preoperative differential diagnosis by MRI was difficult. She underwent three surgical removals. After removal of hemangioblastoma at the first surgery, the juxtaposed tumor grew fast during 3 years. Moreover, 4 years after the second surgery, one of the two adjacent increasing tumors grew faster than another. The pathological diagnoses of both fast-growing tumors were intramedullary metastatic CCRCC, not hemangioblastoma. This patient has no neurological deficits and is now being followed up as an outpatient without any further treatment. LESSONS: Although a rare metastatic intramedullary CCRCC is difficult to differentiate from comorbid hemangioblastomas in patients with VHLD, it is important to note that the tumor growth rate differs between hemangioblastoma and metastatic CCRCC, which can be followed using sequential MRI. Care must be taken not to dismiss the timing of the removal of metastatic intramedullary tumors. https://thejns.org/doi/10.3171/CASE25459.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.